Song Ming-Zhu, Zhang Feng-Lin, Lin Le-Jun
Department of Orthopaedics and Traumatology, Yantaishan Hospital, Yantai, Shandong 264000, P.R. China.
Department of Emergency, Yantai Hospital of Traditional Chinese Medicine, The Affiliated Yantai Yuhuangding Hospital of Qingdao University Medical College, Yantai, Shandong 264000, P.R. China.
Exp Ther Med. 2019 Aug;18(2):1107-1114. doi: 10.3892/etm.2019.7681. Epub 2019 Jun 18.
As one of the leading causes of cancer-associated mortalities worldwide, the overall survival rate of osteosarcoma has stably remained at 15-30% for several decades. (3)- 5,6,7-trihydroxy-3-isopropyl-3-methylisochroman-1-one (TIM), isolated from the whole plant of Hieron., has been reported to have pharmacological activities. In the present study, the anti-proliferative effects of TIM against osteosarcoma were evaluated, and the underlying molecular mechanisms were explored. The results demonstrated that TIM inhibited proliferation and induced apoptosis in U2OS cells. Furthermore, the expression of the pro-apoptotic protein NOXA in the intrinsic apoptosis pathway was upregulated by TIM, while the expression of myeloid cell leukemia 1, an anti-apoptotic protein, was downregulated. In addition, TIM increased the protein expression of the endoplasmic reticulum stress markers inositol-requiring enzyme 1, activating transcription factor 6 and glucose-regulated protein 78. These results suggested that TIM induced ER stress response while activating intrinsic apoptosis. Furthermore, treating osteosarcoma tumor-bearing mice with TIM significantly inhibited the tumor growth in the xenograft animal model. Overall, the study results suggested that TIM may serve as a potential antitumor agent against osteosarcoma.
作为全球癌症相关死亡的主要原因之一,骨肉瘤的总体生存率几十年来一直稳定在15%-30%。从Hieronyma植物全株中分离出的(3)-5,6,7-三羟基-3-异丙基-3-甲基异色满-1-酮(TIM)已被报道具有药理活性。在本研究中,评估了TIM对骨肉瘤的抗增殖作用,并探讨了其潜在的分子机制。结果表明,TIM抑制U2OS细胞的增殖并诱导其凋亡。此外,TIM上调了内源性凋亡途径中促凋亡蛋白NOXA的表达,而下调了抗凋亡蛋白髓样细胞白血病-1的表达。此外,TIM增加了内质网应激标志物肌醇需求酶1、活化转录因子6和葡萄糖调节蛋白78的蛋白表达。这些结果表明,TIM在激活内源性凋亡的同时诱导内质网应激反应。此外,用TIM治疗骨肉瘤荷瘤小鼠在异种移植动物模型中显著抑制了肿瘤生长。总体而言,研究结果表明TIM可能作为一种潜在的抗骨肉瘤抗肿瘤药物。